CULP, INC. FINANCIAL INFORMATION RELEASE | |
CONSOLIDATED STATEMENTS OF CASH FLOWS | |
FOR THE SIX MONTHS ENDED OCTOBER 27, 2013 AND OCTOBER 28, 2012 | |
Unaudited | |
(Amounts in Thousands) | |
| | | | | | |
| | | | | | |
| | SIX MONTHS ENDED | |
| | | | | | |
| | Amounts | |
| | October 27, | | | October 28, | |
| | 2013 | | | 2012 | |
| | | | | | |
Cash flows from operating activities: | | | | | | |
Net income | | $ | 6,326 | | | $ | 11,792 | |
Adjustments to reconcile net income to net cash | | | | | | | | |
provided by operating activities: | | | | | | | | |
Depreciation | | | 2,636 | | | | 2,539 | |
Amortization of other assets | | | 81 | | | | 119 | |
Stock-based compensation | | | 376 | | | | 197 | |
Excess tax benefit related to stock-based compensation | | | (143 | ) | | | (60 | ) |
Deferred income taxes | | | 2,140 | | | | (3,325 | ) |
Gain on sale of equipment | | | (74 | ) | | | - | |
Foreign currency exchange losses (gains) | | | 203 | | | | (66 | ) |
Changes in assets and liabilities, net of effects of acquisition of assets: | | | | | | | | |
Accounts receivable | | | (1,419 | ) | | | 4,353 | |
Inventories | | | (6,331 | ) | | | (1,882 | ) |
Other current assets | | | (437 | ) | | | 373 | |
Other assets | | | (47 | ) | | | (80 | ) |
Accounts payable-trade | | | 5,923 | | | | (7,397 | ) |
Accrued expenses | | | (158 | ) | | | 1,310 | |
Accrued restructuring | | | - | | | | (40 | ) |
Income taxes | | | 367 | | | | (183 | ) |
Net cash provided by operating activities | | | 9,443 | | | | 7,650 | |
| | | | | | | | |
Cash flows from investing activities: | | | | | | | | |
Capital expenditures | | | (1,900 | ) | | | (1,946 | ) |
Net cash paid for acquisition of assets | | | (2,640 | ) | | | - | |
Proceeds from the sale of equipment | | | 113 | | | | - | |
Payments on life insurance policies | | | (30 | ) | | | - | |
Purchase of short-term investments | | | (1,047 | ) | | | (54 | ) |
Proceeds from the sale of short-term investments | | | - | | | | 795 | |
Net cash used in investing activities | | | (5,504 | ) | | | (1,205 | ) |
| | | | | | | | |
Cash flows from financing activities: | | | | | | | | |
Proceeds from lines of credit | | | - | | | | 1,000 | |
Payments on lines of credit | | | - | | | | (1,000 | ) |
Payments on long-term debt | | | (2,200 | ) | | | (2,300 | ) |
Proceeds from common stock issued | | | 194 | | | | 64 | |
Common stock shares repurchased | | | - | | | | (5,022 | ) |
Dividends paid | | | (979 | ) | | | (747 | ) |
Debt issance costs | | | (62 | ) | | | - | |
Excess tax benefit related to stock-based compensation | | | 143 | | | | 60 | |
Net cash used in financing activities | | | (2,904 | ) | | | (7,945 | ) |
| | | | | | | | |
Effect of exchange rate changes on cash and cash equivalents | | | (298 | ) | | | (59 | ) |
| | | | | | | | |
Increase (decrease) in cash and cash equivalents | | | 737 | | | | (1,559 | ) |
| | | | | | | | |
Cash and cash equivalents at beginning of period | | | 23,530 | | | | 25,023 | |
| | | | | | | | |
Cash and cash equivalents at end of period | | $ | 24,267 | | | $ | 23,464 | |
| | | | | | | | |
| | | | | | | | |
Free Cash Flow (1) | | $ | 7,471 | | | $ | 5,705 | |